JP2023534992A5 - - Google Patents
Info
- Publication number
- JP2023534992A5 JP2023534992A5 JP2023504102A JP2023504102A JP2023534992A5 JP 2023534992 A5 JP2023534992 A5 JP 2023534992A5 JP 2023504102 A JP2023504102 A JP 2023504102A JP 2023504102 A JP2023504102 A JP 2023504102A JP 2023534992 A5 JP2023534992 A5 JP 2023534992A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- pharmaceutically acceptable
- acceptable salt
- represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16/932,832 US20200347038A1 (en) | 2014-08-29 | 2020-07-20 | Quinolines that modulate serca and their use for treating disease |
| US16/932,832 | 2020-07-20 | ||
| PCT/US2021/042235 WO2022020261A1 (en) | 2020-07-20 | 2021-07-19 | Quinolines that modulate serca and their use for treating disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023534992A JP2023534992A (ja) | 2023-08-15 |
| JP2023534992A5 true JP2023534992A5 (enExample) | 2024-07-05 |
| JP7705445B2 JP7705445B2 (ja) | 2025-07-09 |
Family
ID=79729478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023504102A Active JP7705445B2 (ja) | 2020-07-20 | 2021-07-19 | Ｓｅｒｃａを調節するキノリン及び疾患を処置するためのその使用 |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP4037685B9 (enExample) |
| JP (1) | JP7705445B2 (enExample) |
| CN (1) | CN116744928A (enExample) |
| CA (1) | CA3186668A1 (enExample) |
| DK (1) | DK4037685T3 (enExample) |
| ES (1) | ES2968041T3 (enExample) |
| FI (1) | FI4037685T3 (enExample) |
| HU (1) | HUE064550T2 (enExample) |
| PL (1) | PL4037685T3 (enExample) |
| PT (1) | PT4037685T (enExample) |
| WO (1) | WO2022020261A1 (enExample) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101784533B (zh) * | 2007-08-22 | 2013-08-21 | 艾博特股份有限两合公司 | 4-苄基氨基喹啉、含有它们的药物组合物和它们在治疗中的用途 |
| CN104302640A (zh) * | 2012-03-16 | 2015-01-21 | 埃克希金医药品有限公司 | 3,5-二氨基吡唑激酶抑制剂 |
| US10772881B2 (en) * | 2017-02-27 | 2020-09-15 | Russell Dahl | Quinolines that modulate SERCA and their use for treating disease |
| US20170281611A1 (en) * | 2014-08-29 | 2017-10-05 | Eiger Biopharmaceuticals, Inc. | Quinolines and their use for treating endoplasmic reticulum stress-caused diseases |
| US20200347038A1 (en) * | 2014-08-29 | 2020-11-05 | Russell Dahl | Quinolines that modulate serca and their use for treating disease |
| CN106966973A (zh) * | 2017-05-18 | 2017-07-21 | 湖北工业大学 | N‑苯基‑n‑（2‑甲基‑8‑喹啉基）苯甲酰胺的制备方法 |
-
2021
- 2021-07-19 CA CA3186668A patent/CA3186668A1/en active Pending
- 2021-07-19 CN CN202180063849.1A patent/CN116744928A/zh active Pending
- 2021-07-19 PT PT218458321T patent/PT4037685T/pt unknown
- 2021-07-19 PL PL21845832.1T patent/PL4037685T3/pl unknown
- 2021-07-19 EP EP21845832.1A patent/EP4037685B9/en active Active
- 2021-07-19 DK DK21845832.1T patent/DK4037685T3/da active
- 2021-07-19 JP JP2023504102A patent/JP7705445B2/ja active Active
- 2021-07-19 ES ES21845832T patent/ES2968041T3/es active Active
- 2021-07-19 WO PCT/US2021/042235 patent/WO2022020261A1/en not_active Ceased
- 2021-07-19 HU HUE21845832A patent/HUE064550T2/hu unknown
- 2021-07-19 FI FIEP21845832.1T patent/FI4037685T3/fi active